Argos Therapeutics, Inc. (ARGS) Stock Analysis
DELISTED 2018
What happened to Argos Therapeutics, Inc. (ARGS) stock?
Argos Therapeutics, Inc. (ARGS) no longer trades on public markets. It was delisted in April 2018. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- April 2018
- Last recorded price (historical):
- $0.2701 (last quote on record before the April 2018 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Argos Therapeutics, Inc. (ARGS). Argos Therapeutics, Inc. is a biotechnology company specializing in personalized immunotherapies for cancer treatment. Their core technology platform utilizes a patient's own tumor RNA to stimulate a targeted immune response.
Last analyzed: Jun 14, 2026Argos Therapeutics, Inc. (ARGS) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ARGS shares?
No. ARGS stopped trading on public markets in April 2018, so the shares are not available through a broker. Anything you see quoted for ARGS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ARGS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Argos Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.